acquired
Stage
About
Ensemble Therapeutics was a biopharmaceutical company founded in 2003 that developed a novel class of therapeutics called Ensemblins™, designed to target drug sites considered inaccessible by conventional small molecules. The company ceased operations in 2017.
Explore Ensemble Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.